Gut microbes in celiac disease pathogenesis and therapy

Celiac Disease: Etiology, Diagnosis, and Treatment

Volumn , Issue , 2009, Pages 33-50

  Sanz, Yolanda ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

Gluten; Gut microbiota; Immunity; Intestinal barrier function; Oral tolerance; Permeability; Probiotics celiac disease

Indexed keywords

EID: 84892102488     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (78)

1. Baba, N., Samson, S., Bourdet-Sicard, R., Rubio, M. & Sarfati, M. (2008). Commensal bacteria trigger a full dendritic cell maturation program that promotes the expansion of non-Tr1 suppressor T cells. J Leukoc Biol., 84, 468-76.
2. Bethune, M.T. & Khosla, C. (2008). Parallels between pathogens and gluten peptides in celiac sprue. PLoS Pathog. 4, e34.
3. Bibiloni, R., Fedorak, R.N., Tannock, G.W., Madsen, K.L., Gionchetti, P., Campieri, M., De Simone, C. & Sartor, R.B. (2005). VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol, 100, 1539-46.
4. Black, K.E., Murray, J.A. & David, C.S. (2002). HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J. Inmunol., 169, 5595-600.
5. Cinova, J., Palová-Jelínková, L., Smythies, L.E., Cerná, M., Pecharová, B., Dvorák, M., Fruhauf, P., Tlaskalová-Hogenová, H., Smith, P.D. & Tucková, L. (2007). Gliadin peptides activate blood monocytes from patients with celiac disease. J Clin Immunol., 27, 201-9.
6. Clemente, M.G., De Virgiliis, S., Kang, J.S., Macatagney, R., Musu, M.P., Di Pierro, M.R., Drago, S., Congia, M. & Fasano, A. (2003) Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 52, 218-23.
7. Collado, M.C., Donat, E., Ribes-Koninckx, C., Calabuig, M. & Sanz, Y. (2008). Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease. BMC Microbiol. 22;8:232.
8. Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. (2009). Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol. 62, 264-9.
9. Corthesy, B., Gaskins, H.R. & Mercenier, A. (2007). Cross-talk between probiotic bacteria and the host immune system. J Nutr, 137, 781-90.
10. Darfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A.L., Barnich, N., Bringer, MA, Swidsinski, A, Beaugerie, L. & Colombel, J.F. (2004). High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology, 127, 412-21.
11. D'Arienzo, R., Maurano, F., Luongo, D., Mazzarella, G., Stefanile, R., Troncone, R, Auricchio, S., Ricca, E., David, C. & Rossi, M. (2008. Adjuvant effect of Lactobacillus casei in a mouse model of gluten sensitivity. Immunol Lett. 119, 78-83.
12. De Stefano, D., Maiuri, M.C., Iovine, B., Ialenti, A., Bevilacqua, M.A. & Carnuccio, R. (2006). The role of NF-kappaB, IRF-1, and STAT-1alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages. J Mol Med, 84, 65-74.
13. Di Sabatino, A., Ciccocioppo, R., Cupelli, F., Cinque, B., Millimaggi,. D, Clarkson, M.M., Paulli, M., Cifone, M.G. & Corazza, G.R. (2006). Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut, 55, 469-77.
14. Fasano A, Catassi C. (2005). Coeliac disease in children. Best Pract Res Clin Gastroenterol. 19, 467-78.
15. Fasano, A. & Shea-Donohue, T. (2005). Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol., 2, 416-22.
16. Flint, H.J., Bayer, E.A. & Rincon, M. T. (2008). Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis, Nat Rev Microbiol., 2, 121-131.
17. Foligne, B., Zoumpopoulou, G., Dewulf, J., Ben Younes, A., Chareyre, F., Sirard, J.C., Pot, B. & Grangette, C. (2007). A key role of dendritic cells in probiotic functionality. PLoS ONE. 21, 2(3):e313.
18. Forchielli, M.L.& Walker, W.A. (2005). The role of gut-associated lymphoid tissues and mucosal defence. Br J Nutr., 93, 41-8
19. Forsberg, G., Fahlgren, A., Hörstedt, P., Hammarström, S.G., Hernell, O. & Hammarström, M.L. (2004). Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am J Gastroenterol., 99, 894-904.
20. Garrote, J.A., Gómez-González, E., Bernardo, D., Arranz, E. & Chirdo, F. (2008). Celiac disease pathogenesis: the proinflammatory cytokine network. J Pediatr Gastroenterol Nutr. 47, Suppl 1, S27-32.
21. Gianfrani, C., Auricchio, S. & Troncone, R. (2005). Adaptive and innate immune responses in celiac disease. Immunol Lett., 99, 141-5.
22. Gophna, U., Sommerfeld, K., Gophna, S., Doolittle, W.F. & Veldhuyzen van Zanten, S.J. (2006). Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol., 44, 4136-41.
23. Greco, L., Romino, R., Coto, I., Di Cosmo, N., Percopo, S., Maglio, M., Paparo, F., Gasperi, V., Limongelli, M.G., Cotichini, R., D'Agate, C., Tinto, N., Sacchetti, L., Tosi, R., & Stazi, MA. (2002). The first large population based twin study of coeliac disease. Gut., 50, 624-8.
24. Green, P.H. & Jabri, B. (2006) Celiac disease. Annu Rev Med., 57, 207-21.
25. Guarner, F., Bourdet-Sicard, R., Brandtzaeg, P., Gill, H. S., McGuirk, P., van Eden, W., Versalovic, J., Weinstock, J. V. & Rook, G. A. (2006) Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol., 3, 275-284.
26. Issekutz, T.B. (1990). Effects of six different cytokines on lymphocyte adherence to microvascular endothelium and in vivo lymphocyte migration in the rat. J Immunol. 144, 2140-6.
27. Ivarsson, A., Hernell, O., Stenlund, H. & Persson, L.A. (2002). Breast-feeding protects against coeliac disease. Am J Clin Nutr. 75, 914-21.
28. Ivarsson, A., Hernell, O., Nystrom, L. & Persson, L.A. (2003). Children born in the summer have increased risk for coeliac disease.J Epidemiol Community Health. 57, 36-9.
29. Jelínková, L., Tucková, L., Cinová, J., Flegelová, Z. & Tlaskalová-Hogenová, H. (2004). Gliadin stimulates human monocytes to production of IL-8 and TNF-alpha through a mechanism involving NF-kappaB. FEBS Lett. 571, 81-5.
30. Kagnoff, M.F (2005) Overview and pathogenesis of celiac disease. Gastroenterology 128, S10-8.
31. Kalliomaki, M., Salminen, S., Poussa, T. & Isolauri, E. (2007). Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol., 119, 1019-21.
32. Kelly, D., Campbell, J.I. & King, T.P. (2004). Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nature Immunology, 5, 1, 104-112.
33. Kirjavainen, P.V., Arvola, T., Salminen, S.J., & Isolauri, E. (2002).Aberrant composition of gut microbiota of allergic infants: a target of bidfidobacterial therapy at weaning? Gut, 51, 51-5.
34. Kotlowski, R., Bernstein, C.N., Sepehri, S. & Krause, D.O. (2007). High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut, 56, 669-75.
35. Lammers, K.M., Lu, R., Brownley, J., Lu, B., Gerard, C., Thoma, K., Rallabhandi, P., Shea-Donohue, T., Tamiz, A., Alkan, S., Netzel-Arnett, S., Antalis, T., Vogel, S.N. & Fasano, A. (2008). Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology, 135, 194-204.
36. Lee, M.S. & Kim, Y.J. (2007). Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem, 76, 447-80.
37. Lindfors, K., Blomqvist, T., Juuti-Uusitalo, K., Stenman, S., Venäläinen, J., Mäki, M. & Kaukinen, K. (2008). Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin Exp Immunol. 152, 552-8.
38. Lodinová-Zádníková, R., Cukrowska, B. & Tlaskalova-Hogenova, H. (2003). Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int Arch Allergy Immunol., 131, 209-11.
39. Macpherson, A.J. & Uhr, T. (2004) Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science, 303, 1662-5.
40. Mazmanian, S.K., Liu, C.H., Tzianabos, A.O. & Kasper, D.L. (2005) An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell, 122, 107-18.
41. Mearin, M.L., Ivarsson, A. & Dickey, W. (2005). Coeliac disease: is it time for mass screening? Best. Pract. Res. Clin. Gastroenterol., 19, 441-52.
42. Medina, M., Izquierdo, E., Ennahar, S. & Sanz, Y. (2007). Differential immunomodulatory properties of Bifidobacterium longum strains: relevance to probiotic selection and clinical applications. Clin Exp Immunol., 150, 531-8.
43. Medina, M., De Palma, G., Ribes-Koninckx, C., Calabuig, M. & Sanz, Y. (2008). Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients. J Inflamm. 3; 5:19.
44. Miyake, M., Hanajima, M., Matsuzawa, T., Kobayashi, C., Minami, M., Abe, A. & Horiguchi, Y. (2005). Binding of intimin with Tir on the bacterial surface is prerequisite for the barrier disruption induced by enteropathogenic Escherichia coli. Biochem Biophys Res Commun. 337, 922-7.
45. Mulder, S.J, & Mulder-Bos, G.C. (2006). Most probable origin of coeliac disease is low immune globulin A in the intestine caused by malfunction of Peyer's patches. Med Hypotheses. 66, 757-62.
46. Nadal, I., Donat, E., Ribes-Koninckx, C., Calabuig, M. & Sanz, Y. (2007). Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol. 56, 669-74.
47. Neish, A.S., Gewirtz, A.T., Zeng, H., Young, A.N., Hobert, M.E., Karmali, V., Rao, A.S. & Madara, J.L. (2000). Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science. 289, 1560-3.
48. Neurath, M.F., Fuss, I., Kelsall, B.L., Presky, D.H., Waegell, W. & Strober, W. (1996). Experimental granulomatous colitis in mice is abrogated by induction of TGF-betamediated oral tolerance. J Exp Med. 183, 2605-16.
49. O'Mahony, C., Scully, P, O'Mahony, D., Murphy, S., O'Brien, F., Lyons, A., Sherlock, G., MacSharry, J., Kiely, B., Shanahan, F. & O'Mahony, L. (2008). Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog., 4, e1000112.
50. Otte, J.M., Cario, E. & Podolsky, D.K. (2004). Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology, 126, 1054-1070.
51. Penders, J., Thijs, C., Vink, C., Stelma, F.F., Snijders, B., Kummeling, I., Van den Brandt, P.A. & Stobberingh, EE. (2006). Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics, 118, 511-21.
52. Rabizadeh, S., Rhee, K.J., Wu, S., Huso, D., Gan, C.M., Golub, J.E., Wu, X., Zhang, M. & Sears, C.L. (200). Enterotoxigenic bacteroides fragilis: a potential instigator of colitis. Inflamm Bowel Dis. 13, 1475-83.
53. Rewers, M. (2005). Epidemiology of coeliac disease: what are the prevalence, incidence, and progression of coeliac disease? Gastroenterology. 128, S47-51.
54. Rubio-Tapia, A., Barton, S.H., Rosenblatt, J.E. & Murray, J.A. (2009). Prevalence of Small Intestine Bacterial Overgrowth Diagnosed by Quantitative Culture of Intestinal Aspirate in Celiac Disease. J Clin Gastroenterol. 43, 157-61.
55. Salvati, V.M., MacDonald, T.T., del Vecchio Blanco, G., Mazzarella, G., Monteleone, I.,Vavassori, P., Auricchio, S., Pallone, F., Troncone, R. & Monteleone, G. (2003). Enhanced expression of interferon regulatory factor-1 in the mucosa of children with celiac disease. Pediatr Res 54, 312-8.
56. Salvati, V.M., Mazzarella, G., Gianfrani, C., Levings, M.K., Stefanile, R., De Giulio, B., Iaquinto, G., Giardullo, N., Auricchio, S., Roncarolo, M.G. & Troncone R (2005) Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa. Gut, 54, 46-53.
57. Sánchez, E., Nadal, I., Donat, E., Ribes-Koninckx, C., Calabuig, M. & Sanz Y. (2008). Reduced diversity and increased virulence-gene carriage in intestinal enterobacteria of coeliac children. BMC Gastroenterol. 4; 8:50.
58. Sanz, Y., Sánchez, E., Marzotto, M., Calabuig, M., Torriani, S. & Dellaglio, F. (2007a). Differences in faecal bacterial communities in coeliac and healthy children as detected by PCR and denaturing gradient gel electrophoresis. FEMS Immunol Med Microbiol., 51, 562-8.
59. Sanz, Y., Nadal, I. & Sánchez, E. (2007b). Probiotics as drugs against gastrointestinal infections. Recent Patents on Anti-Infective Drug Discovery, 2, 148-56.
60. Sanz, Y., Sánchez, E., De Palma, G., Medina, M., Marcos, A., Nova, E. In: Linda, T.O. & Ewente, M R., editors. Child Nutrition & Physiology. New York: Nova Science Publishers, 2008. 210-224.
61. Sartor, R.B. (2008). Microbial influences in inflammatory bowel diseases. Gastroenterol., 134, 577-94.
62. Sanz Y. (2009). Novel perspectives in celiac disease therapy. Mini Rev Med Chem. 9, 359-67.
63. Senger, S., Maurano, F., Mazzeo, M.F., Gaita, M., Fierro, O., David, C.S., Troncone, R., Auricchio, S., Siciliano, R.A. & Rossi, M. (2005). Identification of immunodominant epitopes of alpha-gliadin in HLA-DQ8 transgenic mice following oral immunization. J Immunol., 175, 8087-95.
64. Seth, A., Yan, F., Polk, D.B. & Rao, R.K. (2008). Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol., 294, G1060-9.
65. Sheil, B., MacSharry, J., O'Callaghan, L., O'Riordan, A., Waters, A., Morgan, J., Collins, J.K., O'Mahony, L., & Shanahan, F. (2006). Role of interleukin (IL-10) in probioticmediated immune modulation: an assessment in wild-type and IL-10 knock-out mice. Clin Exp Immunol., 144, 273-80.
66. Stenberg, P., Roth, E.B. & Sjöberg, K. (2008). Transglutaminase and the pathogenesis of coeliac disease. Eur. J. Intern. Med., 19, 83-91.
67. Stene, L.C., Honeyman, M.C., Hoffenberg, E.J., Haas, J.E., Sokol, R.J., Emery, L., Taki, I., Norris, J.M., Erlich, H.A., Eisenbarth, G.S. & Rewers, M. (2006). Rotavirus infection frequency and risk of coeliac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol., 101, 2333-40.
68. Szebeni, B., Veres, G., Dezsofi, A., Rusai, K., Vannay, A., Bokodi, G., Vásárhelyi, B., Korponay-Szabó, I.R, Tulassay, T. & Arató, A. (2007). Increased mucosal expression of Toll-like receptor (TLR)2 and TLR4 in coeliac disease. J Pediatr Gastroenterol Nutr., 45, 187-93.
69. Takaishi, H., Matsuki, T., Nakazawa, A., Takada, T., Kado, S., Asahara, T., Kamada, N., Sakuraba, A., Yajima, T., Higuchi, H., Inoue, N., Ogata, H., Iwao, Y., Nomoto, K., Tanaka, R. & Hibi, T. (2008) Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int J Med Microbiol., 298, 463-72.
70. Terrazzano, G., Sica, M., Gianfrani, C., Mazzarella, G., Maurano, F., De Giulio, B., de Saint-Mezard, S., Zanzi, D., Maiuri, L., Londei, M., Jabri, B., Troncone, R., Auricchio, S., Zappacosta, S. & Carbone, E. (2007). Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization. J Immunol. 179, 372-81.
71. Tjellstrom, B., Stenhammar, L., Hogberg, L., Falth-Magnusson, K., Magnusson, K.E., Midtvedt, T., Sundqvist, T. & Norin, E. (2005). Gut microflora associated characteristics in children with coeliac disease. Am J Gastroenterol., 100, 2784-8.
72. Tjellström, B., Stenhammar, L., Högberg, L., Fälth-Magnusson, K., Magnusson, K.E., Midtvedt, T., Sundqvist, T., Houlston, R., Popat, S. & Norin, E. (2007). Gut microflora associated characteristics in first-degree relatives of children with celiac disease. Scand J Gastroenterol., 42, 1204-8.
73. Van Heel D.A.& West, J. (2006). Recent advances in coeliac disease. Gut. 55, 1037-46.
74. Werner, T. & Haller, D. (2007). Intestinal epithelial cell signalling and chronic inflammation: From the proteome to specific molecular mechanisms. Mutation Research., 622, 42-57.
75. Wu, S., Powell, J., Mathioudakis, N., Kane, S., Fernandez, E. & Sears, C.L. (2004). Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-kappaB pathway. Infect Immun. 72, 5832-9.
76. Wu, S., Shin, J., Zhang, G., Cohen, M., Franco, A. & Sears, C.L. (2006). The Bacteroides fragilis toxin binds to a specific intestinal epithelial cell receptor. Infect Immun. 74, 5382-90.
77. Zanoni, G., Navone, R., Lunardi, C., Tridente, G., Bason, C., Sivori, S., Beri, R., Dolcino, M., Valletta, E., Corrocher, R. & Puccetti, A. (2006). A. In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med., 3, e358.
78. Zeng, J., Li, Y.Q., Zuo, X.L., Zhen, Y.B., Yang, J., Liu, C.H. (2008). Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrheapredominant irritable bowel syndrome. Aliment Pharmacol Ther. Jul 30. [Epub ahead of print]